跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 48,428 条关于
“Cloudbreak Pharma Inc”
全部
48,428
临床试验
15,138
药物
2,634
机构
7,130
资讯
23,526
9个月前
Cloudbreak Therapeutics Advances CBT-004 to Phase 3 Trials Following Successful FDA Meeting for Vascularized Pinguecula Treatment
去年
Cloudbreak Pharma's CBT-004 Achieves Primary Endpoint in Phase 2 Trial for Vascularized Pinguecula
3个月前
CLOUDBREAK-B Receives FDA Clearance for CBT-199 Ophthalmic Drug Trial and Submits IND for Dry Eye Candidate CBT-358
去年
Nuvectis Pharma Reports Financial Results and Highlights Clinical Progress of NXP800 and NXP900
去年
FDA Issues Complete Response Letter for Astellas' Izervay sNDA
去年
Delta-Fly Pharma Advances Solid Tumor and Pancreatic Cancer Programs
去年
Delta-Fly Pharma's Phase I/II Trial of DFP-10917 and Venetoclax Shows Promise in AML
2年前
Delta-Fly Pharma Initiates Phase I/II Trial of DFP-10917 with Venetoclax for Relapsed/Refractory AML
去年
Delta-Fly Pharma's DFP-10917 Shows Promise in Combination with Venetoclax for AML
去年
Delta-Fly Pharma's DFP-10917 Shows Promise in Combination with Venetoclax for AML
第 1 页,共 2353 页
上一页
下一页